Immunoassay is a bioanalytical method used to determine the
presence of a specific factor in the human body, which can be pathogens,
antigens, hormones, antibodies, and enzymes. Furthermore, immunoassays are
capable of quantifying compounds such as macromolecular molecules, biomarkers,
low molecular weight drugs, and metabolites to indicate the diagnosis of
diseases.
Explore More Insights@ https://www.alliedmarketresearch.com/request-toc-and-sample/11245
The increasing incidence of chronic and infectious diseases
has fueled the growth of the automated immunoassay analyzer market across the
globe. Prominent growth in the elderly population prone to infectious diseases
has led to huge demand for diagnostic tests, which has embellished global
industry trends. Innovations in current medical devices and growth in clinical
applications in healthcare sector will increase the scope of automated
immunoassay analyzers industry globally.
The growth of automated immunoassay analyzers market in
North America during the forecast period can be attributed to the growth of
chronic disorders such as heart diseases. Furthermore, the widespread adoption
of new medical devices in the healthcare sector across the North American
subcontinent will further increase the preference for automated immunoassay
analyzers in the region.
COVID-19 Impact Analysis
The widespread use of SARS-CoV-2 antigen rapid immunoassays
for patients infected with COVID-19 has positively impacted the expansion of
the global automated immunoassay analyzer market due to the COVID-19 pandemic.
According to a clinical study by The Lancet, the lateral flow immunoassay
provided accurate diagnosis and results of SARS-CoV-2 antibody tests in
individuals screened for Covid-19 infection.
0 Comments